Inspire Medical Systems, Inc. to Report First Quarter 2026 Financial Results on May 4, 2026
MINNEAPOLIS, April 06, 2026 -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2026 after the close of trading on Monday, May 4. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Zcash price reclaims $800 as coinholders vote on major NU7 changes
Ethereum ETF Inflows Outpace Bitcoin Relative to Market Cap, Analyst Says
Altcoin Season Index Slips to 35: What It Means for Crypto Markets
Crypto Fear and Greed Index Climbs to 82, Extending Extreme Greed Streak
Crypto prices
More
